Supplemental Table 2.docx (14.46 kB)

Supplemental Table 2. Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma

dataset

posted on 2021-05-28, 08:17 authored by Karthik Ramakrishnan, Zhiwen Liu, Shrujal Baxi, Sheenu Chandwani, Sam Joo, Diana Chirovsky

Supplemental Table 2. Real-world time on treatment among patients with R/M HNSCC who initiated second-line systemic therapy on or before December 31, 2018

Funding

Merck

History

Usage metrics

Future Oncology

Keywords

Head and neck squamous-cell carcinoma antineoplastic agents immunological antibodies Kaplan-Meier estimate patient outcomes real-world observational study treatment patterns Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0